# Gastroesophageal Reflux Disease Diagnostic Trial

> **NCT06504134** · — · NOT_YET_RECRUITING · sponsor: **Changhai Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DIAGNOSTIC_TEST:** the Novel Esophageal Cell Collection Device

## Key facts

- **NCT ID:** NCT06504134
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2027-12-31
- **Final completion:** 2027-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2024-07-16

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06504134

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06504134, "Gastroesophageal Reflux Disease Diagnostic Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06504134. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*